JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    •   OpenBU
    • School of Medicine
    • Clinical Science
    • Department of Medicine
    • MED: Medicine Papers
    • View Item
    •   OpenBU
    • School of Medicine
    • Clinical Science
    • Department of Medicine
    • MED: Medicine Papers
    • View Item

    Genetic Analysis of the GRIK2 Modifier Effect in Huntington's Disease

    Thumbnail
    Download/View
    1471-2202-7-62.pdf (314.5Kb)
    License
    Copyright 2006 Zeng et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution 2.0 License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    Date Issued
    2006-9-7
    Related DOI
    10.1186/1471-2202-7-62
    Author
    Zeng, Wenqi
    Gillis, Tammy
    Hakky, Michael
    Djoussé, Luc
    Myers, Richard H
    MacDonald, Marcy E
    Gusella, James F
    Share to FacebookShare to TwitterShare by Email
    Export Citation
    Download to BibTex
    Download to EndNote/RefMan (RIS)
    Metadata
    Show full item record
    Permanent Link
    https://hdl.handle.net/2144/2524
    Citation
    Zeng, Wenqi, Tammy Gillis, Michael Hakky, Luc Djoussé, Richard H Myers, Marcy E MacDonald, James F Gusella. "Genetic analysis of the GRIK2 modifier effect in Huntington's disease" BMC Neuroscience 7:62. (2006)
    Abstract
    BACKGROUND: In Huntington's disease (HD), age at neurological onset is inversely correlated with the length of the CAG trinucleotide repeat mutation, but can be modified by genetic factors beyond the HD gene. Association of a relatively infrequent 16 TAA allele of a trinucleotide repeat polymorphism in the GRIK2 3'UTR with earlier than expected age at neurological onset has been suggested to reflect linkage disequilibrium with a functional polymorphism in GRIK2 or an adjacent gene. RESULTS: We have tested this hypothesis by sequencing all GRIK2 exons, the exon-flanking sequences and 3'UTR in several individuals who were crucial to demonstrating the modifier effect, as they showed much earlier age at neurological onset than would be expected from the length of their HD CAG mutation. Though ten known SNPs were detected, no sequence variants were found in coding or adjacent sequence that could explain the modifier effect by linkage disequilibrium with the 16 TAA allele. Haplotype analysis using microsatellites, known SNPs and new variants discovered in the 3'UTR argues against a common ancestral origin for the 16 TAA repeat alleles in these individuals. CONCLUSION: These data suggest that the modifier effect is actually due to the TAA repeat itself, possibly via a functional consequence on the GRIK2 mRNA.
    Rights
    Copyright 2006 Zeng et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution 2.0 License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    Collections
    • MED: Medicine Papers [229]
    • MED: Neurology Papers [66]

    Contact Us | Send Feedback | Help
     

     

    Browse

    All of OpenBUCommunities & CollectionsIssue DateAuthorsTitlesSubjectsThis CollectionIssue DateAuthorsTitlesSubjects

    Deposit Materials

    LoginNon-BU Registration

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Contact Us | Send Feedback | Help